edoc

Items where Division is "03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Hämatologie > Molekulare Medizin (Skoda)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Hämatologie > Molekulare Medizin (Skoda)"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Creators | Refereed
Jump to: B | C | G | H | L | P | S | U | Z
Number of items at this level: 19.

B

Bertozzi, Cara C. and Schmaier, Alec A. and Mericko, Patricia and Hess, Paul R. and Zou, Zhiying and Chen, Mei and Chen, Chiu-Yu and Xu, Bin and Lu, Min-min and Zhou, Diane and Sebzda, Eric and Santore, Matthew T. and Merianos, Demetri J. and Stadtfeld, Matthias and Flake, Alan W. and Graf, Thomas and Skoda, Radek and Maltzman, Jonathan S. and Koretzky, Gary A. and Kahn, Mark L.. (2010) Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood, Vol. 116, H. 4. pp. 661-670.

C

Chagraoui, Hedia and Kassouf, Mira and Banerjee, Sreemoti and Goardon, Nicolas and Clark, Kevin and Atzberger, Ann and Pearce, Andrew C. and Skoda, Radek C. and Ferguson, David J. P. and Watson, Steve P. and Vyas, Paresh and Porcher, Catherine. (2011) SCL-mediated regulation of the cell-cycle regulator p21 is critical for murine megakaryopoiesis. Blood, Vol. 118, H. 3. pp. 723-735.

G

Grisouard, Jean and Li, Sai and Kubovcakova, Lucia and Rao, Tata Nageswara and Meyer, Sara C. and Lundberg, Pontus and Hao-Shen, Hui and Romanet, Vincent and Murakami, Masato and Radimerski, Thomas and Dirnhofer, Stephan and Skoda, Radek C.. (2016) JAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis. Blood, 128 (6). pp. 839-851.

H

Holbro, Andreas and Skoda, Radek and Lundberg, Pontus and Passweg, Jakob and Buser, Andreas and Lehmann, Thomas. (2015) Erythropoietin receptor mutation--a rush of blood to the head? Annals of hematology, 94 (7). pp. 1229-1231.

L

Li, Sai. Studies of JAK2 mutations in myeloproliferative disorders. 2008, Doctoral Thesis, University of Basel, Faculty of Science.

Liu, Kun. Genetic studies of familial myeloproliferative disorders. 2007, Doctoral Thesis, University of Basel, Faculty of Science.

P

Pianta, Annalisa. Genetic studies of hereditary thrombocythemia. 2013, Doctoral Thesis, University of Basel, Faculty of Science.

Passamonti, Francesco and Elena, Chiara and Schnittger, Susanne and Skoda, Radek C. and Green, Anthony R. and Girodon, François and Kiladjian, Jean-Jacques and McMullin, Mary Frances and Ruggeri, Marco and Besses, Carles and Vannucchi, Alessandro M. and Lippert, Eric and Gisslinger, Heinz and Rumi, Elisa and Lehmann, Thomas and Ortmann, Christina A. and Pietra, Daniela and Pascutto, Cristiana and Haferlach, Torsten and Cazzola, Mario. (2011) Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. Blood, Vol. 117, H. 10. pp. 2813-2816.

Posthuma, Hidde L. A. and Skoda, Radek C. and Jacob, Frank A. and van der Maas, Anthonie P. C. and Valk, Peter J. M. and Posthuma, Eduardus F. M.. (2010) Hereditary thrombocytosis not as innocent as thought? Development into acute leukemia and myelofibrosis. Blood, Vol. 116, H. 17. pp. 3375-3376.

Pan, Dejing. Transforming growth factor-ß (TGF-ß) signaling in hematopoiesis and tumorigenesis. 2008, Doctoral Thesis, University of Basel, Faculty of Science.

S

Schaub, Franz X. and Lehmann, Thomas and Looser, Renate and Hao-Shen, Hui and Tichelli, Andre and Skoda, Radek C.. (2011) Transition to homozygosity does not appear to provide a clonal advantage to hematopoietic progenitors carrying mutations in TET2. Blood, Vol. 117, H. 6. pp. 2075-2076.

Skoda, R. C. and Schwaller, J.. (2011) HiJAKing the methylosome in myeloproliferative disorders. Cancer cell, Vol. 19, H. 2. pp. 161-163.

Schaub, Franz X. and Looser, Renate and Li, Sai and Hao-Shen, Hui and Lehmann, Thomas and Tichelli, Andre and Skoda, Radek C.. (2010) Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood, Vol. 115, H. 10. pp. 2003-2007.

Schaub, Franz Xaver. Clonal evolution of mutation events in myeloproliferative neoplasms. 2010, Doctoral Thesis, University of Basel, Faculty of Science.

Skoda, . (2010) Hereditary myeloproliferative disorders. Haematologica, Vol. 95, H. 1. pp. 6-8.

Skoda, R. C.. (2010) JAK2 impairs stem cell function? Blood, Vol. 116, H. 9. pp. 1392-1393.

U

Ungureanu, Daniela and Wu, Jinhua and Pekkala, Tuija and Niranjan, Yashavanthi and Young, Clifford and Jensen, Ole N. and Xu, Chong-Feng and Neubert, Thomas A. and Skoda, Radek C. and Hubbard, Stevan R. and Silvennoinen, Olli. (2011) The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling. Nature structural & molecular biology, Vol. 18, no. 9. pp. 971-976.

Z

Zmajkovic, Jakub. Genetic studies of hereditary myeloproliferative disorders. 2018, Doctoral Thesis, University of Basel, Faculty of Science.

Zhang, G. and Xiang, B. and Dong, A. and Skoda, R. C. and Daugherty, A. and Smyth, S. S. and Du, X. and Li, Z.. (2011) Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation. Blood, Vol. 118, H. 13. pp. 3670-3679.

This list was generated on Fri Dec 13 03:51:28 2019 CET.